301 related articles for article (PubMed ID: 30796966)
1. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
Gene; 2019 May; 697():57-66. PubMed ID: 30796966
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
Wee Y; Wang T; Liu Y; Li X; Zhao M
Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
[TBL] [Abstract][Full Text] [Related]
3. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
5. Evolution of oncogenic signatures of mutation hotspots in tyrosine kinases supports the atavistic hypothesis of cancer.
Chen W; Li Y; Wang Z
Sci Rep; 2018 May; 8(1):8256. PubMed ID: 29844492
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
7. Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes.
Balestrieri C; Vanoni M; Hautaniemi S; Alberghina L; Chiaradonna F
Biotechnol Adv; 2012; 30(1):16-29. PubMed ID: 21736933
[TBL] [Abstract][Full Text] [Related]
8. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.
Kato S; Weng QY; Insco ML; Chen KY; Muralidhar S; Pozniak J; Diaz JMS; Drier Y; Nguyen N; Lo JA; van Rooijen E; Kemeny LV; Zhan Y; Feng Y; Silkworth W; Powell CT; Liau BB; Xiong Y; Jin J; Newton-Bishop J; Zon LI; Bernstein BE; Fisher DE
Cancer Discov; 2020 Jul; 10(7):980-997. PubMed ID: 32269030
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive overview of oncogenic pathways in human cancer.
Li F; Wu T; Xu Y; Dong Q; Xiao J; Xu Y; Li Q; Zhang C; Gao J; Liu L; Hu X; Huang J; Li X; Zhang Y
Brief Bioinform; 2020 May; 21(3):957-969. PubMed ID: 31155677
[TBL] [Abstract][Full Text] [Related]
11. Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer.
Bielski CM; Donoghue MTA; Gadiya M; Hanrahan AJ; Won HH; Chang MT; Jonsson P; Penson AV; Gorelick A; Harris C; Schram AM; Syed A; Zehir A; Chapman PB; Hyman DM; Solit DB; Shannon K; Chandarlapaty S; Berger MF; Taylor BS
Cancer Cell; 2018 Nov; 34(5):852-862.e4. PubMed ID: 30393068
[TBL] [Abstract][Full Text] [Related]
12. Identification of the functional alteration signatures across different cancer types with support vector machine and feature analysis.
Wang S; Cai Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2218-2227. PubMed ID: 29277326
[TBL] [Abstract][Full Text] [Related]
13. Shared and unique mutational gene co-occurrences in cancers.
Liu J; Zhao D; Fan R
Biochem Biophys Res Commun; 2015 Oct; 465(4):777-83. PubMed ID: 26315265
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators.
Simeone I; Ceccarelli M
J Transl Med; 2023 Jan; 21(1):55. PubMed ID: 36717859
[TBL] [Abstract][Full Text] [Related]
16. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Wang G; Anastassiou D
Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
[TBL] [Abstract][Full Text] [Related]
18. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
Willis S; Hutchins AM; Hammet F; Ciciulla J; Soo WK; White D; van der Spek P; Henderson MA; Gish K; Venter DJ; Armes JE
Genes Chromosomes Cancer; 2003 Apr; 36(4):382-92. PubMed ID: 12619162
[TBL] [Abstract][Full Text] [Related]
19. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
[TBL] [Abstract][Full Text] [Related]
20. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
